Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by bluemoons20on Nov 24, 2022 1:26pm
66 Views
Post# 35125638

RE:RE:Arbitration

RE:RE:Arbitration This is crazy.  From the way I see the  rules,  the parties  have about  90  days  following initiation  to  put their case out  and  agree on the  arbitrator. 

Then  they have a hearing   and  have some to and  from.  Then  60  days  (or less)  after the hearing ends the arbitrator  must  send the decision (award).

The hearing has to have been held  by  now  unless the parties  agree to  extend to  have  private  talks  (maybe  settlement)??


Either  way  there is no  good reason  for  the company  not telling  us  they have  paused the  arbitration,   had  the  hearing  etc.  some  followup as to where they are in the process  is not unreasonable.

Even if they are trying to  reach a  joint settlement  we could be  told  that  fact.  There should be nothing secretive  about  where we are in the process!!

This is all  crazy.   An  up and down arbitration should have been long over by  now!!

GLTA
<< Previous
Bullboard Posts
Next >>